Mercedes Parra-Macias

Mexico City, DIF, MX 
Mexico City, DIF, MX 

Overview

Mercedes Parra-Macias practices practicing medicine in Mexico City, Mexico.

Her clinical expertise encompasses Chickenpox, Intussusception in Children, Togaviridae Disease, and Bacterial Meningitis.

She is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Mexico City, DIF, Mexico
Other Locations
La Ciudad, DUR, Mexico
Mexico, MEX, Mexico
Paso Nacional, OAX, Mexico
Av. Insurgentes Sur 3700-C Insurgentes Cuicuilco, Insurgentes Cuicuilco, DIF 04530, Mexico
Guanajuato, GUA, Mexico
Insurgentes Cuicuilco, CP 04530, Coyoacan, DIF 04530, Mexico

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2

26 Total Publications

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.
Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.
Journal: The Pediatric infectious disease journal
Published: July 04, 2026

Frequently Asked Questions about Mercedes Parra-Macias

Is Mercedes Parra-Macias a top-rated expert for Chickenpox?

MediFind is an objective health platform that identifies experts based on real-world data. Mercedes Parra-Macias is classified as an Experienced expert for Chickenpox, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mercedes Parra-Macias participate in research or clinical trials?

Yes. Mercedes Parra-Macias has published 26 articles and abstracts on conditions like Chickenpox. You can view a list of Mercedes Parra-Macias's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Parra-Macias's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile